Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of ANTG-ASC on Complex Fistula
NCT01314092Phase 2Terminated
- Sponsor
- Anterogen Co., Ltd.
- Start
- Jan 2011
- Primary completion
- Sep 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of adipose-derived mesenchymal stem cell in perianal fistula, sponsored by Anterogen Co., Ltd.. Started Jan 2011; status: terminated.
02
Drugs
adipose-derived mesenchymal stem cell
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT01314092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314092.